Letters to the Editor

Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials

Hematology Unit and Biotechnology Research Unit, Azienda Ospedaliera of Cosenza, Cosenza, Italy;
Hematology Section, University of Bari, Italy;
Department of Hematology, Businco Hospital, Cagliari, Italy;
Hematology and Bone Marrow Transplant Unit, Ospedale Papa Giovanni XXIII, Bergamo, Italy;
Hematology Unit and Biotechnology Research Unit, Azienda Ospedaliera of Cosenza, Cosenza, Italy;
Hematology Unit, Ospedale Cardarelli, Napoli, Italy;
Dept of medica and surgical specialties, Hematology Section, University of Catania, Catania, Italy;
Onco-hematology Unit, Ospedale Umberto I, Nocera Inferiore, Italy;
Hematology Unit, Parma University Hospital, Italy;
Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy;
UOC Ematologia a Indirizzo Oncologico, AORN;
Onco-hematology Unit Azienda Ospedaliera Santa Maria of Terni, Italy;
Internal Medicine, Ospedale S. Croce, Ospedali Riuniti Marche Nord, Fano, Italy;
Ematologia, Università Cattolica, Fondazione Policlinico Gemelli IRCCS, Roma, Italy;
Hematology Unit, Careggi Hospital, Florence, Italy;
Department of Biomedical Science, University of Bari;
Medicine, Hematology and Clinical Immunology, Padua University School of Medicine, Padua, Italy;
Hematology Unit, UOC Lecce, Italy;
Hematology Unit, Antonio Perrino Hospital, Brindisi, Italy;
Hematology and Bone Marrow Transplant Unit, Fondazione 'G. Pascale', IRCCS, Napoli, Italy;
Hematology and Stem Cell Transplantation, IRCCS-CROB, Rionero in Vulture, Italy;
Department of Hematology, Hospital University Riuniti, Foggia, Italy;
Hematology and Bone Marrow Transplant, Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy;
Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy;
Hematology Unit, A.O. Spedali Civili, Brescia, Italy;
Hematology Unit, AO S.G. Moscati, Aversa, Italy;
Hematology Department, G. Garibaldi Hospital, Catania, Italy;
Hematology Section, University of Bari, Italy;
Hematology Unit and Biotechnology Research Unit, Azienda Ospedaliera of Cosenza, Cosenza, Italy;
Hematology Unit and Biotechnology Research Unit, Azienda Ospedaliera of Cosenza, Cosenza, Italy;
Hematology Unit, Great Metropolitan Hospital;
Section of Hematology, Department of Medicine, University of Verona, Verona, Italy;
Hematology Unit and Pathology Department, S. Eugenio Hospital Rome, Rome, Italy;
Hematology, DISM, University of Udine, Italy;
Hemato-Oncology and Radiotherapy, Great Metropolitan Hospital;
Hematology, Ospedale Santa Maria della Misericordia, University of Perugia, Perugia, Italy;
Hematology Unit, Fabrizio Spaziani Hospital, Frosinone, Italy;
Complex Operative Unit of Hematology, S. Maria di Loreto Nuovo Hospital, Napoli, Italy;
Hematology Unit, AUSL-IRCCS, Reggio Emilia, Italy;
Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy;
Biotechnology Research Unit, Azienda Ospedaliera of Cosenza, Cosenza, Italy;
Nephrology Center of National Research Institute, Reggio Calabria, Italy;
CNR-IFC, Roma, Italy;
UOC Ematologia a Indirizzo Oncologico, AORN;
Hematology Department, G. Garibaldi Hospital, Catania, Italy;
Div of Hematology,University of Torino,AOU Città della Salute e della Scienza di Torino,Italy;
Seragnoli Institute of Hematology and Medical Oncology, University of Bologna, Bologna, Italy;
Hematology, DISM, University of Udine, Italy;
Istituto di Ematologia, Università Cattolica,Fondazione Policlinico Gemelli IRCCS,Roma,Italy;
Department of Medical and Surgical Specialties, Hematology Section, University of Catania, Italy;
Hematology Unit, Ospedale Cardarelli, Napoli, Italy;
Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Italy;
Hematology Unit, AOU Ospedali Riuniti di Ancona, Italy;
Div of Hematology,University of Torino,AOU Città della Salute e della Scienza di Torino,Italy;
Seragnoli Institute of Hematology and Medical Oncology, University of Bologna, Bologna, Italy;
Hemato-Oncology Department, Augusta Victoria Hospital of Jerusalem, Israel
Haematologica Early view Feb 27, 2020 https://doi.org/10.3324/haematol.2019.241513